m+Medelevator.RU
← Поиск публикаций
Nature · 2025

Detecting structural heart disease from electrocardiograms using AI.

СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Poterucha Timothy J, Jing Linyuan, Ricart Ramon Pimentel, Adjei-Mosi Michael, Finer Joshua, Hartzel Dustin, Kelsey Christopher, Long Aaron, Rocha Daniel, Ruhl Jeffrey A, vanMaanen David, Probst Marc A, Daniels Brock, Joshi Shalmali D, Tastet Olivier, Corbin Denis, Avram Robert, Barrios Joshua P, Tison Geoffrey H, Chiu I-Min, Ouyang David, Volodarskiy Alexander, Castillo Michelle, Roedan Oliver Francisco A, Malta Paloma P, Ye Siqin, Rosner Gregg F, Dizon Jose M, Ali Shah R, Liu Qi, Bradley Corey K, Vaishnava Prashant, Waksmonski Carol A, DeFilippis Ersilia M, Agarwal Vratika, Lebehn Mark, Kampaktsis Polydoros N, Shames Sofia, Beecy Ashley N, Kumaraiah Deepa, Homma Shunichi, Schwartz Allan, Hahn Rebecca T, Leon Martin, Einstein Andrew J, Maurer Mathew S, Hartman Heidi S, Hughes John Weston, Haggerty Christopher M, Elias Pierre

Аннотация

Early detection of structural heart disease is critical to improving outcomes, but widespread screening remains limited by the cost and accessibility of imaging tools such as echocardiography1,2. Recent advances in machine learning applied to heart rhythm recordings have shown promise in identifying disease3,4, although previous work has been limited by development in narrow populations or targeting only select heart conditions5. Here we introduce a deep learning model, EchoNext, trained on more than 1 million heart rhythm and imaging records across a large and diverse health system to detect many forms of structural heart disease. The model demonstrated high diagnostic accuracy in internal and external validation, outperforming cardiologists in a controlled evaluation and showing consistent performance across different care settings and racial and/or ethnic groups. The models were prospectively evaluated in a clinical trial of patients without previous cardiac imaging, successfully identifying previously undiagnosed heart disease. These findings support the potential of artificial intelligence to expand access to heart disease screening at scale. To enable further development and transparency, we have publicly released model weights and a large, annotated dataset linking heart rhythm data to imaging-based diagnoses.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты